Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21

Cell Metabolism

Volumn 8, Issue 1, 2008, Pages 77-83

  Inagaki, Takeshi ^a   Lin, Vicky Y ^a,b   Goetz, Regina ^c   Mohammadi, Moosa ^c   Mangelsdorf, David J ^a,b   Kliewer, Steven A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HUMDISEASE; SIGNALING

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GENE EXPRESSION; GROWTH INHIBITION; HORMONE INHIBITION; HORMONE RESISTANCE; INHIBITION KINETICS; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STARVATION; TRANSGENIC MOUSE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; FASTING; FIBROBLAST GROWTH FACTORS; GROWTH; GROWTH HORMONE; LIVER; MICE; SIGNAL TRANSDUCTION; STARVATION; STAT5 TRANSCRIPTION FACTOR;

MUS;

EID: 45649085226     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2008.05.006     Document Type: Article

References (37)

1. Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., and Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007) 426-437
2. Baxter R.C., and Martin J.L. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog. Growth Factor Res. 1 (1989) 49-68
3. Beauloye V., Willems B., de Coninck V., Frank S.J., Edery M., and Thissen J.P. Impairment of liver GH receptor signaling by fasting. Endocrinology 143 (2002) 792-800
4. Bornfeldt K.E., Arnqvist H.J., Enberg B., Mathews L.S., and Norstedt G. Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J. Endocrinol. 122 (1989) 651-656
5. Clemmons D.R. Role of insulin-like growth factor in maintaining normal glucose homeostasis. Horm. Res. 62 Suppl 1 (2004) 77-82
6. Davey H.W., McLachlan M.J., Wilkins R.J., Hilton D.J., and Adams T.E. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol. Cell. Endocrinol. 158 (1999) 111-116
7. Davey H.W., Xie T., McLachlan M.J., Wilkins R.J., Waxman D.J., and Grattan D.R. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142 (2001) 3836-3841
8. Davidson M.B. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr. Rev. 8 (1987) 115-131
9. Emler C.A., and Schalch D.S. Nutritionally-induced changes in hepatic insulin-like growth factor I (IGF-I) gene expression in rats. Endocrinology 120 (1987) 832-834
10. Greenhalgh C.J., Bertolino P., Asa S.L., Metcalf D., Corbin J.E., Adams T.E., Davey H.W., Nicola N.A., Hilton D.J., and Alexander W.S. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol. Endocrinol. 16 (2002) 1394-1406
11. Greenhalgh C.J., Rico-Bautista E., Lorentzon M., Thaus A.L., Morgan P.O., Willson T.A., Zervoudakis P., Metcalf D., Street I., Nicola N.A., et al. SOCS2 negatively regulates growth hormone action in vitro and in vivo. J. Clin. Invest. 115 (2005) 397-406
12. Guo S., Rena G., Cichy S., He X., Cohen P., and Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274 (1999) 17184-17192
13. Herrington J., Smit L.S., Schwartz J., and Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 19 (2000) 2585-2597
14. Holloway M.G., Cui Y., Laz E.V., Hosui A., Hennighausen L., and Waxman D.J. Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology 148 (2007) 1977-1986
15. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., Li Y., Goetz R., Mohammadi M., Esser V., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007) 415-425
16. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., Sandusky G.E., Hammond L.J., Moyers J.S., Owens R.A., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115 (2005) 1627-1635
17. Kong S.E., Baxter R.C., and Delhanty P.J. Age-dependent regulation of the acid-labile subunit in response to fasting-refeeding in rats. Endocrinology 143 (2002) 4505-4512
18. Leroith D., and Nissley P. Knock your SOCS off!. J. Clin. Invest. 115 (2005) 233-236
19. LeRoith D., and Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 302-310
20. Lowe Jr. W.L., Adamo M., Werner H., Roberts Jr. C.T., and LeRoith D. Regulation by fasting of rat insulin-like growth factor I and its receptor. Effects on gene expression and binding. J. Clin. Invest. 84 (1989) 619-626
21. Lundåsen T., Hunt M.C., Nilsson L.M., Sanyal S., Angelin B., Alexson S.E., and Rudling M. PPARalpha is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 360 (2007) 437-440
22. Maes M., Underwood L.E., and Ketelslegers J.M. Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites. J. Endocrinol. 97 (1983) 243-252
23. Metcalf D., Greenhalgh C.J., Viney E., Willson T.A., Starr R., Nicola N.A., Hilton D.J., and Alexander W.S. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405 (2000) 1069-1073
24. Murphy L.J., Seneviratne C., Moreira P., and Reid R.E. Enhanced expression of insulin-like growth factor-binding protein-I in the fasted rat: the effects of insulin and growth hormone administration. Endocrinology 128 (1991) 689-696
25. Ogawa Y., Kurosu H., Yamamoto M., Nandi A., Rosenblatt K.P., Goetz R., Eliseenkova A.V., Mohammadi M., and Kuro-o M. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. USA 104 (2007) 7432-7437
26. Ono M., Chia D.J., Merino-Martinez R., Flores-Morales A., Unterman T.G., and Rotwein P. Signal transducer and activator of transcription (Stat) 5b-mediated inhibition of insulin-like growth factor binding protein-1 gene transcription: a mechanism for repression of gene expression by growth hormone. Mol. Endocrinol. 21 (2007) 1443-1457
27. Rico-Bautista E., Flores-Morales A., and Fernández-Pérez L. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev. 17 (2006) 431-439
28. Ruotolo G., Båvenholm P., Brismar K., Eféndic S., Ericsson C.G., de Faire U., Nilsson J., and Hamsten A. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J. Am. Coll. Cardiol. 35 (2000) 647-654
29. Seneviratne C., Luo J.M., and Murphy L.J. Transcriptional regulation of rat insulin-like growth factor-binding protein-1 expression by growth hormone. Mol. Endocrinol. 4 (1990) 1199-1204
30. Shipley J.M., and Waxman D.J. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b. Toxicol. Appl. Pharmacol. 199 (2004) 275-284
31. Silha J.V., and Murphy L.J. Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143 (2002) 3711-3714
32. Suzuki M., Uehara Y., Motomura-Matsuzaka K., Oki J., Koyama Y., Kimura M., Asada M., Komi-Kuramochi A., Oka S., and Imamura T. {beta}Klotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol. 22 (2008) 1006-1014
33. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., and Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 (1998) 841-850
34. Thissen J.P., Ketelslegers J.M., and Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15 (1994) 80-101
35. Underwood L.E., Thissen J.P., Lemozy S., Ketelslegers J.M., and Clemmons D.R. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm. Res. 42 (1994) 145-151
36. Woelfle J., and Rotwein P. In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E393-E401
37. Yakar S., Liu J.L., Stannard B., Butler A., Accili D., Sauer B., and LeRoith D. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 96 (1999) 7324-7329